Agree. Production and Distribution all day long. $EVOK is going to the big leagues with their innovative new product Gimoti. Can’t wait to see what the potential is for this company when doctors are prescribing the drug and sales figures start rolling in. $8 to $10 easy from these levels in my opinion. $10 is also the average price target from the analysts covering Evoke. $10 pps gives this a $280 million dollar market cap. Realistic for a first if it’s kind delivery system for metoclopramide. Or you could listen to someone scream the stocks going to $2 10 times a day for 6 weeks. Sounds legit.
News 
Market Data 
Discover 
